Insurance rules hamper treatment for opioid use disorder
An effort to control costs in the insurance industry could be helping to fuel the nation's opioid epidemic, a new study says.From 2007 to 2018, Medicare part D patient access to buprenorphine fell from 89 percent in 2007 to 35 percent in 2018, despite its effectiveness in treating opioid use disorder, according to a research letter published Tuesday in the Journal of the American Medical Association.
Continue Reading https://www.upi.com
Join the Discussion